Karla J. Posekany

546 total citations
9 papers, 488 citations indexed

About

Karla J. Posekany is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Karla J. Posekany has authored 9 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Surgery and 3 papers in Oncology. Recurrent topics in Karla J. Posekany's work include Ubiquitin and proteasome pathways (3 papers), Xenotransplantation and immune response (3 papers) and Retinoids in leukemia and cellular processes (2 papers). Karla J. Posekany is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Xenotransplantation and immune response (3 papers) and Retinoids in leukemia and cellular processes (2 papers). Karla J. Posekany collaborates with scholars based in United States and United Kingdom. Karla J. Posekany's co-authors include Peter J. Parker, Paul Cook, D. Kirk Ways, Jerry L. Hooker, Donald J. Fletcher, Cindy Kukoly, James DeVente, Kathryn M. Verbanac, Carl E. Haisch and John F. Bradfield and has published in prestigious journals such as Journal of Clinical Investigation, Infection and Immunity and Oncology Reports.

In The Last Decade

Karla J. Posekany

9 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karla J. Posekany United States 7 360 119 73 67 52 9 488
Karl J. Mathis United States 10 303 0.8× 78 0.7× 62 0.8× 63 0.9× 23 0.4× 17 509
Dan Rosson United States 11 483 1.3× 80 0.7× 55 0.8× 76 1.1× 30 0.6× 17 610
Kyoichiro Higashi Japan 11 399 1.1× 110 0.9× 63 0.9× 29 0.4× 37 0.7× 15 628
Hexiao Wang China 10 346 1.0× 139 1.2× 134 1.8× 46 0.7× 61 1.2× 18 538
Barbara Lamb United States 18 418 1.2× 80 0.7× 90 1.2× 129 1.9× 38 0.7× 27 633
T Seguchi Japan 11 262 0.7× 51 0.4× 66 0.9× 35 0.5× 73 1.4× 16 418
William A. Ricketts United States 7 265 0.7× 54 0.5× 57 0.8× 28 0.4× 23 0.4× 10 475
Debbie Hall United Kingdom 10 429 1.2× 133 1.1× 110 1.5× 33 0.5× 14 0.3× 12 590
Pushpankur Ghoshal United States 15 289 0.8× 81 0.7× 88 1.2× 39 0.6× 55 1.1× 23 520
Keli Song United States 10 336 0.9× 120 1.0× 58 0.8× 37 0.6× 18 0.3× 19 475

Countries citing papers authored by Karla J. Posekany

Since Specialization
Citations

This map shows the geographic impact of Karla J. Posekany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla J. Posekany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla J. Posekany more than expected).

Fields of papers citing papers by Karla J. Posekany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karla J. Posekany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla J. Posekany. The network helps show where Karla J. Posekany may publish in the future.

Co-authorship network of co-authors of Karla J. Posekany

This figure shows the co-authorship network connecting the top 25 collaborators of Karla J. Posekany. A scholar is included among the top collaborators of Karla J. Posekany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karla J. Posekany. Karla J. Posekany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Posekany, Karla J., John E. Wiley, & Gregory Gagnon. (2009). A novel method to display [gal alpha1, 3 gal] antigens on human leukemic cells for preparation of anti-leukemia vaccines.. PubMed. 29(6). 2387–92. 2 indexed citations
2.
Posekany, Karla J., et al.. (2004). Suppression of Lewis lung tumor development in alpha 1,3 galactosyltransferase knock-out mice.. PubMed. 24(2B). 605–12. 6 indexed citations
3.
Posekany, Karla J., et al.. (2002). Induction of Cytolytic Anti-Gal Antibodies in α-1,3-Galactosyltransferase Gene Knockout Mice by Oral Inoculation withEscherichia coliO86:B7 Bacteria. Infection and Immunity. 70(11). 6215–6222. 61 indexed citations
4.
DeVente, James, et al.. (1996). Phorbol ester stimulated Cip1 expression in p53-negative leukemic cells. Oncology Reports. 3(1). 213–7. 2 indexed citations
5.
Kukoly, Cindy, Karla J. Posekany, Donald J. Fletcher, et al.. (1995). Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms. Role for p53-independent induction of gadd-45 in initiating death.. Journal of Clinical Investigation. 96(4). 1874–1886. 64 indexed citations
6.
Wiley, John E., et al.. (1995). Cytogenetic and flow cytometric analysis of a pancreatoblastoma. Cancer Genetics and Cytogenetics. 79(2). 115–118. 12 indexed citations
7.
Ways, D. Kirk, Cindy Kukoly, James DeVente, et al.. (1995). MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.. Journal of Clinical Investigation. 95(4). 1906–1915. 239 indexed citations
8.
Hooker, Jerry L., Karla J. Posekany, Peter J. Parker, et al.. (1995). Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation.. PubMed. 6(4). 371–82. 49 indexed citations
9.
Ways, D. Kirk, Karla J. Posekany, James DeVente, et al.. (1994). Overexpression of protein kinase C-zeta stimulates leukemic cell differentiation.. PubMed. 5(11). 1195–203. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl J. Mathis Breakdown of academic impact, for papers by Dan Rosson Breakdown of academic impact, for papers by Kyoichiro Higashi Breakdown of academic impact, for papers by Hexiao Wang Breakdown of academic impact, for papers by Barbara Lamb Breakdown of academic impact, for papers by T Seguchi Breakdown of academic impact, for papers by William A. Ricketts Breakdown of academic impact, for papers by Debbie Hall Breakdown of academic impact, for papers by Pushpankur Ghoshal Breakdown of academic impact, for papers by Keli Song
Rankless by CCL
2026